Categories: News

PeriGen Adds Accomplished Physician and Quality Leader to Consult on Programs on Remote Patient Monitoring, Product Development and Physician Engagement

CARY, N.C., April 12, 2022 /PRNewswire/ — PeriGen Inc., the market leader in FDA-cleared computerized maternal-fetal early warning systems today announced that Kimberlee McKay, MD F.A.C.O.G. is joining PeriGen as a physician consultant. Dr. McKay currently serves as the Clinical Vice President OB/GYN Service Line at Avera Health, an integrated health system based in Sioux Falls, SD, and serving patients across five states in the upper Midwest. A long-time user of PeriGen analytics, Dr. McKay brings hands on experience and expertise with patient safety and quality programs, healthcare equity and rural maternity care, as well as remote patient monitoring. At PeriGen, she will be instrumental in expanding PeriGen’s commitment to centralized remote patient monitoring, physician engagement and emerging primary care opportunities.

“Dr. McKay has enjoyed great success applying PeriGen systems to improve the quality and consistency of perinatal care across Avera’s broad and diverse footprint, which includes clinics, community hospitals and tertiary care centers,” said Matthew Sappern, PeriGen CEO. “She is an extremely engaged and constructive customer and an advocate and example for adopting innovation to tackle challenges across geographic and socioeconomic boundaries.”

“Every obstetrics service line in the nation faces costly challenges of consistency and standardization in care and communication, but these issues are magnified several times over for health systems covering less densely populated geographies” said Dr. McKay. “Innovations such as PeriGen’s AI early monitoring software are an effective way to ensure sustainable quality of care and I look forward to helping the company continue to evolve its suite of AI-powered tools and services.”

About PeriGen
PeriGen Inc., a Halma company, offers innovative perinatal software solutions that incorporate advanced statistical analysis features to enhance clinical efficiency and standardization of care during childbirth. Led by skilled OB practitioners and IT visionaries, PeriGen has created the PeriWatch® platform to provide consistent analysis and efficient display of complex data to promote better human recognition and communication about impending problems during labor. With PeriWatch®, clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation. To learn more, visit www.perigen.com; visit us on Twitter, LinkedIn, YouTube, and Facebook; or email info@perigen.com.

Media Contacts:

Amendola Communications for PeriGen Inc.
Grant Evans
gevans@acmarketingpr.com
(215) 582-8146

View original content to download multimedia:https://www.prnewswire.com/news-releases/perigen-adds-accomplished-physician-and-quality-leader-to-consult-on-programs-on-remote-patient-monitoring-product-development-and-physician-engagement-301523400.html

SOURCE PeriGen

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

1 hour ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

4 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

4 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

4 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

4 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

4 hours ago